As we move into a digital reality, data has emerged as the backbone of operations across all industries. Real-time data provides actionable insights, and retrospective analysis surfaces opportunities for attaining best practices and measuring progress towards goals. Furthermore, the collection of data builds out predictive analytics to identify patterns and trends that help anticipate future needs.
In healthcare, there is nothing more important than ensuring patient safety. Advancements in healthcare technology have enabled clinicians to collect, review and leverage more data than ever before in order to achieve optimal patient safety.
Using Data at Every Stage of the Journey to Impact Change Management
During Becker’s Hospital Review’s most recent webinar, Glytec’s Chief Medical Officer, Dr. Jordan Messler, MD, SFHM, FACP, and the University of New Mexico Health Sciences in Albuquerque's Dr. Kendall Rogers, MD, CPE, FACP, SFHM, discussed how to use data at every stage of a patient’s and institution’s journey to impact change and drive improvement. During the webinar, Dr. Rogers explained the role data plays in each stage of the journey.
Here are the key takeaways from the webinar:
Healthcare organizations continue to search for ways to improve monitoring and treatment of patients managing glycemic issues. By collecting, organizing and displaying the right data, facilities and providers can drive change within glycemic programs.
Learn more about how you can use data to improve patient outcomes and drive change management.
MAR-0000352 Rev 1.0
©Copyright 2023 Glytec, LLC on behalf of Aseko, Inc. | Terms of Use | Legal Disclaimer | Privacy Policy | Contraindications, Warnings and Precautions
The eGlycemic Management System® is a modularized solution for glycemic management across the care continuum that includes Glucommander™. Glucommander™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.
Glucommander™ is only available for use in the United States.
This site is only intended for use in the United States.
Aseko is a registered trademark of Aseko, Inc.